Eplerenone
NDC Package 73320-005-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Eplerenone is a medication used alone or in combination with other medicines to treat high blood pressure. Marketed by Kartha Pharmaceuticals, Inc., this product is identified by NDC 73320-005 and is authorized under FDA application ANDA214663.

Identification & Billing

NDC Package Code
73320-005-07
Package Description
10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
73320-005
11-Digit Billing Format
73320000507

Clinical Specifications

Proprietary Name
Eplerenone
Dosage Form
-
Usage Information
This medication is used alone or in combination with other medicines to treat high blood pressure. It works by blocking a chemical (aldosterone) in your body which in turn lowers the amount of sodium and water the body retains. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. It is also used to treat congestive heart failure following a heart attack.

Regulatory & Marketing

Labeler Name
Kartha Pharmaceuticals, Inc.
FDA Application #
ANDA214663
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-01-2023
End Marketing Date
04-02-2023
Listing Expiration
04-02-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73320-005). Click a package code to view its specific billing and regulatory data.

73320-005-01
30 TABLET, FILM COATED in 1 BOTTLE
73320-005-06
90 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73320-005-07 identifies a specific commercial package of 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack of Eplerenone, labeled by Kartha Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kartha Pharmaceuticals, Inc. on April 01, 2023. The current certification is valid through April 02, 2023.

What are the primary indications for this medication?

This medication is used alone or in combination with other medicines to treat high blood pressure. It works by blocking a chemical (aldosterone) in your body which in turn lowers the amount of sodium and water the body retains. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. It is also used to treat congestive heart failure following a heart attack.

How is this Kartha Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73320000507. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73320-005-07
11-Digit CMS (5-4-2)
73320-0005-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.